Pharmacological control of intimal hyperplasia in small diameter polytetrafluoroethylene grafts: An experimental study

International Angiology

Volumn 15, Issue 1, 1996, Pages 50-56

  Simoni, G ^a,b   Galleano, R ^a   Civalleri, D ^a   Decian, F ^a   Desalvo, P ^a   Ceppa, P ^a   Baccini, P ^a   Lenti, E ^a   Bachi, V ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiplatelet drugs; Heparin, low molecular weight; Intimal hyperplasia; Vascular grafts

Indexed keywords

ANTITHROMBOCYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; POLITEF; TICLOPIDINE;

ANIMAL EXPERIMENT; ARTERY ENDOTHELIUM; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFICACY; GRAFT OCCLUSION; NONHUMAN; ORAL DRUG ADMINISTRATION; POLITEF IMPLANT; POSTOPERATIVE CARE; SHEEP; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS;

ANIMALS; BLOOD VESSEL PROSTHESIS; CAROTID ARTERIES; CAROTID ARTERY THROMBOSIS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HEPARIN, LOW-MOLECULAR-WEIGHT; HYPERPLASIA; MALE; POLYTETRAFLUOROETHYLENE; POSTOPERATIVE CARE; SHEEP; TICLOPIDINE; TUNICA INTIMA; VASCULAR PATENCY;

EID: 0029976210     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Veith FJ, Gupta SK, Ascer E et al. Six-years prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstruction. J Vasc Surg 1986;3:104-14.
2. McCarthy WJ, Pearce WH, Flinn WR et al. Long-term evaluation of composite sequential bypass for limb threatening ischemia. J Vasc Surg 1992;15(5):761-70.
3. Clowes AW Regulation of smooth muscle cell function by heparin. J Vasc Surg 1992;15(5):911-3.
4. Green RM, Roedersheimer R, DeWeese JA. Effects of aspirine and dipyridamole on expanded polytetrafluoroethylene graft patency Surgery 1982;92:1016-26.
5. Clagett GP, Genton E, Salzmann EW. Antithrombotic therapy in peripheral vascular disease. Chest 1989;95: 128S-39S.
6. Balsano F, Coccheri S, Libretti A et al. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial. J Lab Clin Med 1989;114:84-91.
7. Wilson NV, Salisbury JR, Kakkar W. Effect of low molecular weight heparin on intimal hyperplasia. Br J Surg 1991;78:1381-3.
8. Esquivel CO, Bjorck CG, Bergentz SE et al. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding. Surgery 1984;95:102-7.
9. Guide for the care and the use of laboratory animals, NIH Publication No. 86-23, revised 1985.
10. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia - A review. J Vasc Surg 1991;13(6): 885-91.
11. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:420-5.
12. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Nat Acad Sci USA 1991;88:3739-43.
13. Clowes AW, Clowes MM. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats. Lab Invest 1980;6:535-41.
14. Kohler TR, Jawien A, Clowes AW. Effect of shear on intimal hyperplasia following arterial injury in rats. Circulation 1990;82(Suppl):400.
15. Watase M, Kambayashi J, Itoh T et al. Ultrastructural analysis of pseudo-intimal hyperplasia of polytetrafluoroethylene prostheses implanted into the venous and arterial system. Eur J Vasc Surg 1992;6:371-80.
16. Majesky MW, Schwartz SM, Clowes MM, Clowes AW. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 1987;61:296-300.
17. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 1986;58:839-45.
18. Hoover RL, Rosenberg R, Hearing W, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res 1980; 47:578-83.
19. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977;265:625-6.
20. Majack RA, Clowes AW. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 1984;118:253-6.
21. Snow AD, Bolender RP, Wight TN, Clowes AW. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 1990;137:313-30.
22. Guyton JR, Rosenberg R, Clowes AW, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin. I. In vivo studies with anticoagulant and non-anticoagulant heparin. Circ Res 1980; 46:625-34.
23. Clowes AW, Rosenberg RD, Clowes MM. Regulation of arterial smooth muscle cell proliferation by heparin in vivo. Surg Forum 1983;34:357-60.
24. Buchwald AB, Unterberg C, Nebendhal K, Grone JH, Wiegand V. Low molecular weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs. Circulation 1992;86:531-7.
25. Hanke H, Oberhoff M, Hanke S et al. Inhibition of cellular proliferation after experimental balloon angioplasty by low molecular weight heparin. Circulation 1992;85:1548-56.
26. Gloviczki P, Hollier LH, Dewanjee MK, Trastek VF, Kopesky KR, Kaye MP. Quantitative evaluation of ibuprofen treatent on thrombogenicity of expanded polytetrafluoroethylene vascular grafts. Surgery 1984; 95(2):160-8.
27. Harker LA, Slichter SJ, Sauvage LR. Platelet consumption by arterial prosthesis: the effects of endothelization and pharmacologic inhibition of platelet function. Ann Surg 1977;186:594-601.
28. Clyne CAC, Archer TJ, Atuhaire LK, Chante ADB, Webster JHH. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femoro-distal grafts. Br J Surg 1987;74:246-8.
29. Carson S, Demlig R, Esquivel C, Talken L, Tillman P. Testing and treatment of arterial graft thrombosis. Am J Surg 1981;142:137-42.
30. Wilson NV, Salisbury JR, Kakkar VV. The effect of low molecular weight heparin on intimal hyperplasia in vein grafts. Eur J Vasg Surg 1994;8:60-4.
31. Sottiurai VS, Yao JST, Flinn WR, Batson RC. Intimal hyperplasia and neointima: and ultrastructural analysis of thrombosed grafts in humans. Surgery 1983; 93:809-17.